These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24457077)

  • 1. c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma.
    Leventaki V; Drakos E; Karanikou M; Psatha K; Lin P; Schlette E; Eliopoulos A; Vassilakopoulos TP; Papadaki H; Patsouris E; Medeiros LJ; Rassidakis GZ
    Hum Pathol; 2014 Mar; 45(3):565-72. PubMed ID: 24457077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
    Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
    Janz M; Hummel M; Truss M; Wollert-Wulf B; Mathas S; Jöhrens K; Hagemeier C; Bommert K; Stein H; Dörken B; Bargou RC
    Blood; 2006 Mar; 107(6):2536-9. PubMed ID: 16263788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.
    Mathas S; Hinz M; Anagnostopoulos I; Krappmann D; Lietz A; Jundt F; Bommert K; Mechta-Grigoriou F; Stein H; Dörken B; Scheidereit C
    EMBO J; 2002 Aug; 21(15):4104-13. PubMed ID: 12145210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells.
    Bai M; Tsanou E; Agnantis NJ; Kamina S; Grepi C; Stefanaki K; Rontogianni D; Galani V; Kanavaros P
    Mod Pathol; 2004 Nov; 17(11):1338-45. PubMed ID: 15354186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.
    Nie K; Gomez M; Landgraf P; Garcia JF; Liu Y; Tan LH; Chadburn A; Tuschl T; Knowles DM; Tam W
    Am J Pathol; 2008 Jul; 173(1):242-52. PubMed ID: 18583325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G
    Zhang J; Wu Z; Savin A; Yang M; Hsu YR; Jantuan E; Bacani JTC; Ingham RJ
    Sci Rep; 2018 Oct; 8(1):16019. PubMed ID: 30375407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.
    Zhang Q; Yang Z; Jia Z; Liu C; Guo C; Lu H; Chen P; Ma K; Wang W; Zhou C
    Mol Cancer; 2014 Jul; 13():181. PubMed ID: 25070240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.
    Xie L; Ushmorov A; Leithäuser F; Guan H; Steidl C; Färbinger J; Pelzer C; Vogel MJ; Maier HJ; Gascoyne RD; Möller P; Wirth T
    Blood; 2012 Apr; 119(15):3503-11. PubMed ID: 22343918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma are highly dependent on oxidative phosphorylation.
    Birkenmeier K; Dröse S; Wittig I; Winkelmann R; Käfer V; Döring C; Hartmann S; Wenz T; Reichert AS; Brandt U; Hansmann ML
    Int J Cancer; 2016 May; 138(9):2231-46. PubMed ID: 26595876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.
    Rengstl B; Kim S; Döring C; Weiser C; Bein J; Bankov K; Herling M; Newrzela S; Hansmann ML; Hartmann S
    PLoS One; 2017; 12(5):e0177378. PubMed ID: 28505189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
    Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
    Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin lymphoma: Pathology and biology.
    Mathas S; Hartmann S; Küppers R
    Semin Hematol; 2016 Jul; 53(3):139-47. PubMed ID: 27496304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.